- Home
- PEPG
PEPG
PepGen Inc.
as 04-23-2025 4:00pm EST
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | N/A | IPO Year: | 2022 |
| Target Price: | $10.33 | AVG Volume (30 days): | 267.8K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.85 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.88 - $19.30 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of PepGen Inc. (PEPG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| McArthur James G | PEPG | President and CEO | Apr 17 '25 | Buy | $1.36 | 10,000 | $13,550.00 | 113,913 | |
| McArthur James G | PEPG | President and CEO | Apr 8 '25 | Buy | $1.15 | 41,500 | $47,725.00 | 113,913 | |
| Donnelly Noel | PEPG | Chief Financial Officer | Feb 24 '25 | Sell | $1.68 | 1,527 | $2,565.36 | 1,673 | |
| DeLena Mary Beth | PEPG | General Counsel | Feb 24 '25 | Sell | $1.68 | 1,432 | $2,405.76 | 1,568 |
Latest PepGen Inc. News
PEPG Breaking Stock News: Dive into PEPG Ticker-Specific Updates for Smart Investing
Simply Wall St.
9 days ago
Is PepGen (NASDAQ:PEPG) In A Good Position To Deliver On Growth Plans?
Business Wire
22 days ago
PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference
Business Wire
24 days ago
PepGen Announces Appointment of Two New Directors to its Board
Business Wire
a month ago
PepGen Announces Presentations at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
Clinical Trials Arena
2 months ago
PepGen pauses Phase II DMD trial to review safety data
MT Newswires
2 months ago
PepGen to Pause Study in Duchenne Muscular Dystrophy; Shares Down Pre-Bell
Business Wire
2 months ago
PepGen to Participate in Upcoming Investor Conferences
Business Wire
2 months ago
PepGen Announces Update to Phase 2 CONNECT2-EDO51 Study in Patients with DMD
Compare PEPG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PEPG PepGen Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.